Unlock instant, AI-driven research and patent intelligence for your innovation.

Use of natural mulberry glucoside

A natural product, the technology of mulberry glycosides, which is applied in the directions of medical preparations containing active ingredients, drug combinations, respiratory diseases, etc., to achieve the effects of no toxic side effects, no addiction, and small dosage.

Inactive Publication Date: 2010-02-10
SHENYANG PHARMA UNIVERSITY
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although some central antitussives with less dependence, such as dextromethorphan (dextromethorphan), have been developed through modification or synthesis based on the analysis of the structure-activity relationship of morphine alkaloids, their side effects also need to be paid attention to in use. full attention

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of natural mulberry glucoside
  • Use of natural mulberry glucoside
  • Use of natural mulberry glucoside

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] Ammonia antitussive test in mice:

[0016] Mulberry glucoside (MUL) was administered ig at 0.04g / kg, 0.08g / kg, and 0.16g / kg, in a 4L bell jar, sprayed into concentrated ammonia water (25%) 8 times at constant pressure, and observed the cough latency and cough within 3min frequency. The blank control was 1% sodium carboxymethylcellulose, and the positive drug was pentoxyverine. The experimental results show (see table 1): mulberry glycoside (MUL) 0.08g / kg, 0.16g / kg can prolong the cough incubation period, the middle dose group (0.08g / kg) has significant difference compared with the blank group, the high dose group (0.16mg / kg) compared with the blank group has a very significant difference. The middle-dose group (0.08g / kg) and the high-dose group (0.16g / kg) can reduce the number of coughs in mice, and there are extremely significant differences compared with the blank group.

[0017] Table 1 The effect of mulberry glycosides on ammonia induced cough mice (x ± s)

[00...

Embodiment 2

[0022] Sulfur dioxide induced coughing method in mice

[0023] Mulberry glycoside (MUL) is administered with 0.01g / kg, 0.02g / kg, 0.04g / kg ig, after 1.5h after the administration, mice are put into a 250ml wide-mouth bottle filled with 5ml sulfur dioxide, and the cough latency is observed And the number of coughs within 3 minutes. The blank control was 1% sodium carboxymethylcellulose, and the positive drug was pentoxyverine suspension. The experimental results show (see Table 2): the high dose group (0.04g / kg) of molaritin (MUL), the middle dose group (0.02g / kg), and the low dose group (0.01g / kg) can all reduce the 3min The number of coughs within the low-dose group and the middle-dose group had significant differences compared with the blank group, and the high-dose group had a very significant difference compared with the blank group.

[0024] Table 2 The effect of mulberry glycosides on sulfur dioxide-induced cough mice (x ± s)

[0025]

[0026] * p** p<0.01 VS Contr...

Embodiment 3

[0028] guinea pig citric acid cough method

[0029] Mulberry glycoside (MUL) is administered with 0.02g / kg, 0.10g / kg, 0.20g / kg ig, puts into the experimental container after 1.5h after the administration, sprays into 40% citric acid solution with throat sprayer, Record the incubation period of the guinea pig cough, and the number of coughs within 5 minutes. The blank control was 1% sodium carboxymethylcellulose, and the positive drug was 0.01 g / kg of pentoxyverine suspension. The results show (see Table 3): the high-dose group (0.20g / kg) of mulberry glycoside (MUL), and the middle-dose group (0.10g / kg), both can prolong the cough latency of the factory guinea pig, and the middle-dose group is compared with the blank group There are significant differences, and there are extremely significant differences between the high-dose group and the blank group.

[0030] The effect of table 3 moriside on citric acid induced cough guinea pigs (n=8, x ± s)

[0031]

[0032] Guinea Pi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

An application of the mulberroside 3-[2-[4-(beta-D-puran glucosyl-oxy-2-hydroxyphenyl)-(E)-vinyl]-5-hydroxyphenyl-beta-D -puran glucoside in preparing the medicines for treating cough and asthma is disclosed. Its advantages are no addiction and no toxic by-effect.

Description

Technical field: [0001] The invention relates to the technical field of medicine, and discloses the new application of mulberroside A in the pharmaceutical field for the first time. It is a stilbene glycoside extracted from natural plants, Chinese medicinal materials or Chinese medicinal pieces, which has a significant antitussive effect and a certain antiasthmatic effect. Specifically, the chemical structure of the natural product is 3-[2-[4-(β-D-glucopyranosyl-oxygen-2-hydroxyphenyl)-(E)-vinyl]-5-hydroxybenzene β-D-glucopyranoside. Background technique: [0002] Due to the ever-changing human living environment, the incidence of respiratory diseases caused by human sensitivity and environmental pollution continues to rise, and cough is one of the common symptoms of respiratory diseases. Most of the antitussives currently used clinically are chemical drugs and compound preparations of traditional Chinese medicines. According to the mechanism of antitussive action, chemic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/7034A61P11/14A61P11/06
Inventor 邱峰
Owner SHENYANG PHARMA UNIVERSITY